Experience with leflunomide as treatment and as secondary prophylaxis for cytomegalovirus infection in lung transplant recipients: A case series and review of the literature

Data concerning the use of leflunomide—a drug approved for rheumatoid arthritis with in vitro anticytomegalovirus (CMV) activity—in lung transplant (LT) recipients are scarce.

[1]  D. Goldstein,et al.  Utility of Leflunomide in the Treatment of Drug Resistant Cytomegalovirus Retinitis , 2017, Ocular immunology and inflammation.

[2]  D. Navarro,et al.  Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. , 2016, Transplantation reviews.

[3]  T. Kiser,et al.  Use of a Cholestyramine Washout in a Patient With Septic Shock on Leflunomide Therapy , 2016, Journal of intensive care medicine.

[4]  T. Lesnick,et al.  Cytomegalovirus disease is associated with higher all‐cause mortality after lung transplantation despite extended antiviral prophylaxis , 2016, Clinical transplantation.

[5]  N. Mueller,et al.  The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  Y. Becker,et al.  Use of Leflunomide in Renal Transplant Recipients with Ganciclovir-Resistant/Refractory Cytomegalovirus Infection: A Case Series from the University of Chicago , 2015, Case Reports in Nephrology and Dialysis.

[7]  H. Nitschko,et al.  Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[8]  L. Pączek,et al.  Cytomegaloviral infection in solid organ transplant recipients: preliminary report of one transplant center experience. , 2014, Transplantation proceedings.

[9]  K. Mucha,et al.  Leflunomide as a rescue treatment in ganciclovir-resistant cytomegalovirus infection in a seronegative renal transplant recipient--a case report. , 2014, Annals of transplantation.

[10]  H. Hoogsteden,et al.  Leflunomide as part of the treatment for multidrug‐resistant cytomegalovirus disease after lung transplantation: case report and review of the literature , 2013, Transplant infectious disease : an official journal of the Transplantation Society.

[11]  S. Levine,et al.  Lung transplant infection , 2012, Respirology.

[12]  A. Caliendo,et al.  Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. , 2013, Transplantation.

[13]  G. John,et al.  Leflunomide for cytomegalovirus: bench to bedside , 2012, Transplant infectious disease : an official journal of the Transplantation Society.

[14]  R. Razonable,et al.  New Developments in the Management of Cytomegalovirus Infection after Solid Organ Transplantation , 2010, Drugs.

[15]  D. Snydman.  Leflunomide: a small step forward in meeting the urgent need for treatment of drug-resistant cytomegalovirus infection. , 2010, Transplantation.

[16]  W. Braun,et al.  Utility of Leflunomide in the Treatment of Complex Cytomegalovirus Syndromes , 2010, Transplantation.

[17]  M. Fischereder,et al.  Leflunomide: a treatment option for ganciclovir-resistant cytomegalovirus infection after renal transplantation , 2009, NDT plus.

[18]  M. Battiwalla,et al.  Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation , 2007, Transplant infectious disease : an official journal of the Transplantation Society.

[19]  S. Chandy,et al.  A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients. , 2005, Transplantation proceedings.

[20]  C. Crumpacker,et al.  Sequencing of Cytomegalovirus UL97 Gene for Genotypic Antiviral Resistance Testing , 2001, Antimicrobial Agents and Chemotherapy.

[21]  C. Crumpacker,et al.  Interstrain Variation in the Human Cytomegalovirus DNA Polymerase Sequence and Its Effect on Genotypic Diagnosis of Antiviral Drug Resistance , 1999, Antimicrobial Agents and Chemotherapy.